As research shows
ARA-290 (cibinetide) is a synthetic 11-amino acid peptide derived from the tissue-protective domain (helix B surface) of erythropoietin (EPO). It is engineered to selectively activate the innate repair receptor (IRR / EPOR-CD131 heterocomplex), providing potent anti-inflammatory, neuroprotective, and tissue-protective effects without stimulating erythropoiesis (red blood cell production). 
It is primarily researched for its potential in small fiber neuropathy, diabetic complications, ischemic injury, and reducing chronic inflammation while supporting nerve regeneration and metabolic health.
key benefits
>>Promotes tissue protection and repair via innate repair receptor activation
>>Supports nerve regeneration and reduces neuropathic symptoms
>>Reduces inflammation and oxidative stress without hematologic effects
>>Explored for photoprotection, cardiac health, and metabolic benefits
Potential studies on neuropathy, kidney protection, and anti-aging pathways
Important note: For research use only